VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Purchased by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC grew its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 1,104.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 30,194 shares of the company’s stock after purchasing an additional 27,687 shares during the period. Kingsview Wealth Management LLC’s holdings in VanEck Pharmaceutical ETF were worth $2,739,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in PPH. Allworth Financial LP acquired a new stake in VanEck Pharmaceutical ETF during the fourth quarter worth about $28,000. Global Retirement Partners LLC boosted its holdings in VanEck Pharmaceutical ETF by 2,343.8% during the 1st quarter. Global Retirement Partners LLC now owns 391 shares of the company’s stock valued at $35,000 after acquiring an additional 375 shares during the period. Almanack Investment Partners LLC. acquired a new position in VanEck Pharmaceutical ETF in the 4th quarter valued at about $225,000. Edge Financial Advisors LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the first quarter worth $248,000. Finally, Private Client Services LLC purchased a new position in VanEck Pharmaceutical ETF in the fourth quarter valued at $298,000.

VanEck Pharmaceutical ETF Price Performance

Shares of VanEck Pharmaceutical ETF stock traded up $0.43 on Friday, reaching $91.90. 45,333 shares of the company were exchanged, compared to its average volume of 136,675. The stock’s 50 day moving average price is $91.39 and its 200-day moving average price is $88.84. VanEck Pharmaceutical ETF has a 1-year low of $74.05 and a 1-year high of $93.85. The company has a market cap of $610.22 million, a P/E ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, July 5th. Stockholders of record on Monday, July 1st were given a dividend of $0.3558 per share. The ex-dividend date was Monday, July 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.